BRIEF published on 07/23/2026 at 16:01, 1 month 13 days ago ABL Diagnostics falls below the 95% threshold Growth Strategy Stock Liquidity Majority Shareholder ABL Diagnostics Widening Of The Floating
BRIEF published on 07/23/2026 at 09:27, 1 month 13 days ago ABL Diagnostics takes over TEXCELL's activities Investment ABL Diagnostics Virology Genopole TEXCELL Takeover
PRESS RELEASE published on 07/23/2026 at 09:22, 1 month 13 days ago Inside Information / Other news releases ABL Diagnostics selected by the \u00c9vry Commercial Court to acquire TEXCELL's operations, enhancing life sciences and infectious diseases activities at Genopole Acquisition Molecular Diagnostics ABL Diagnostics Genopole TEXCELL
BRIEF published on 07/13/2026 at 08:05, 1 month 24 days ago Half-yearly review of the ABL Diagnostics Liquidity Contract in 2026 Liquidity Contract Stock Market Transactions ABL Diagnostics Half-year Review First Half Of 2026
BRIEF published on 06/18/2026 at 13:57, 2 months 17 days ago ABL Diagnostics: Growth and Outlook for 2026 INVEST SECURITIES Growth Partnerships Molecular Diagnosis Genotyping
BRIEF published on 06/18/2026 at 13:57, 2 months 17 days ago ABL Diagnostics Projects Notable Growth and Upward Potential Strategic Partnerships Revenue Increase Buy Recommendation ABL Diagnostics Growth 2026
PRESS RELEASE published on 06/18/2026 at 13:52, 2 months 17 days ago Inside Information / Other news releases ABL Diagnostics confirms growth trajectory with strong upside potential. Invest Securities raises target price to €8.7 and maintains 'Buy' recommendation INVEST SECURITIES Target Price Growth Trajectory Upside Potential ABL Diagnostics
BRIEF published on 06/12/2026 at 08:05, 2 months 24 days ago ABL Diagnostics and CDL Pharma Secure €2.7 Million Contract Clinical Program Neurodegenerative Diseases International Contract ABL Diagnostics CDL Pharma
BRIEF published on 06/12/2026 at 08:05, 2 months 24 days ago ABL Diagnostics and CDL Pharma sign a €2.7 million contract until 2031 Clinical Trials Neurodegenerative Diseases ABL Diagnostics Multi-year Contract CDL Pharma
PRESS RELEASE published on 06/12/2026 at 08:00, 2 months 24 days ago Inside Information / Other news releases ABL Diagnostics and CDL Pharma secure a multi-year international contract of up to €2.7 million through 2031. The contract involves services for neurodegenerative disease clinical programs across North America, Europe, and Asia Neurodegenerative Diseases ABL Diagnostics Multi-year Contract CDL Pharma International Clinical Program
Published on 09/05/2026 at 04:05, 1 day 4 hours ago Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Published on 09/04/2026 at 23:30, 1 day 8 hours ago FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 1 day 9 hours ago Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 1 day 9 hours ago Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/04/2026 at 14:30, 1 day 17 hours ago Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)
Published on 09/06/2026 at 06:00, 2 hours 7 minutes ago CoolFly to Showcase Personal Flight Portfolio and NA80 Flight-Control Technology at IFA Berlin 2026
Published on 09/06/2026 at 05:15, 2 hours 52 minutes ago Experience AI Companion in Everyday Life at Hisense IFA 2026
Published on 09/05/2026 at 22:20, 9 hours 47 minutes ago PITAKA Marks Its Next Chapter in Berlin With "Signals in the Wind," Unveiling New iPhone 18 Accessories
Published on 09/05/2026 at 19:35, 12 hours 32 minutes ago ToolDance Unveils X1 Smart Desktop CNC Mill at IFA 2026
Published on 09/05/2026 at 14:00, 18 hours 7 minutes ago Global investment boom could create USD 200 billion commercial insurance opportunity amid rising accumulation risks, finds Swiss Re Institute
Published on 09/04/2026 at 18:57, 1 day 13 hours ago Disclosure of transactions in own shares from September 1 to September 4, 2026
Published on 09/04/2026 at 17:45, 1 day 14 hours ago Declaration of voting rights at the end of August 2026
Published on 09/04/2026 at 16:00, 1 day 16 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2026
Published on 09/04/2026 at 16:00, 1 day 16 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2026
